Molecular Epidemiology of Breast Cancer among Iranian-Azeri Population based on P۵۳ Research

Publish Year: 1397
نوع سند: مقاله ژورنالی
زبان: English
View: 131

This Paper With 15 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_JKMU-25-3_005

تاریخ نمایه سازی: 19 دی 1401

Abstract:

Background: This study was done in order to enhance our understanding about molecular and epidemiological features of breast cancer among the Azeri population with special emphasis on the detection of TP۵۳ mutations. We also analyzed the role of the P۵۳codon۷۲ polymorphism (rs۱۰۴۲۵۲۲) and its role in susceptibility to breast cancer. Methods: Tumor and control samples were collected from ۲۴۸ patients and ۱۸۹ controls. TP۵۳ mutations in exons۴-۹ and adjacent intronic regions were detected by direct sequencing in ۱۳۰ of these tumor samples. Allele-specific PCR amplification (ARMS-PCR) was used to detect polymorphisms at P۵۳codon۷۲ in ۲۴۸ patients and ۱۸۹ controls. Data were analyzed using χ۲ test or Fisher's exact and a p value of Results: We identified alterations in ۱۷.۶۹% of the exonic and intronic regions within the TP۵۳. We detected ۲۳ mutant and ۱۰۷ non-mutant samples. These mutations comprised ۲۱ single-base substitutions (۱۵-transitions and ۶-transversions), one deletion and one complex. Exon۶ was identified as a highly mutable region, with ten out of all ۲۳ (۴۳.۴۷%) observed mutations. We did not observe a significant association between polymorphism and mutation status (p >۰.۰۵). Also, the results did not show a significant correlation between P۵۳ mutational status and clinicopathological features. Distribution differences in the P۵۳codon۷۲ polymorphism between the cases and controls were not statistically significant (p >۰.۰۵). Conclusion: It might be concluded that P۵۳ mutational status and codon۷۲ polymorphism could not be considered as biomarker for breast cancer risk and its clinical features in the studied population. However, further investigations are needed to support these findings.

Authors

Nasser Pouladi

Assistant Professor of Cellular & Molecular Biology, Department of Biology, Faculty of Science, Azarbaijan Shahid Madani University, Tabriz, Iran

Mohammad-Ali HosseinpourFeizi

Professor of Radiobiology, Department of Biology, Faculty of Natural Science, University of Tabriz, Tabriz, Iran

Shideh Montasser Kouhsari

Associate Professor of Molecular Biology & Biochemistry, Department of Cellular and Molecular Biology, School of Biology, College of Sciences, University of Tehran, Tehran, Iran

Davoud Farajzadeh

Assistant Professor of Cellular & Molecular Biology, Department of Biology, Faculty of Science, Azarbaijan Shahid Madani University, Tabriz, Iran

Hourieh Khani

Ph.D. candidate of Molecular Genetics, Department of Biology, Faculty of Natural Science, University of Tabriz, Tabriz, Iran

Reyhaneh Ravanbakhsh Gavgani

Ph.D. candidate of Molecular Genetics, Department of Biology, Faculty of Natural Science, University of Tabriz, Tabriz, Iran

Narges Dastmalch

M.Sc. of Molecular Genetics, Department of Biology, Faculty of Natural Science, University of Tabriz, Tabriz, Iran

Yalda Arghavanian

M.Sc. of Molecular Genetics, Department of Biology, Faculty of Natural Science, University of Tabriz, Tabriz, Iran

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • American Cancer Society. Breast Cancer Facts & Figures ۲۰۱۳-۲۰۱۴. Atlanta: ...
  • Forouzanfar MH, Foreman KJ, Delossantos AM, Lozano R, Lopez AD, ...
  • Pouladi N, Kouhsari SM, Feizi MH, Dehghan R, Azarfam P, ...
  • Xu Y, Deng Q, He B, Pan Y, Li R, ...
  • Levine AJ, Oren M. The first ۳۰ years of p۵۳: ...
  • Vousden KH, Prives C. Blinded by the light: the growing ...
  • Hosking CR. Celebrating ۳۰ years of p۵۳ research. Trends in ...
  • Pouladi N, Kouhsari SM, Feizi MH, Gavgani RR, Azarfam P. ...
  • Aylon Y, Oren M. The Paradox of p۵۳: What, How, ...
  • Whibley C, Pharoah PD, Hollstein M. p۵۳ polymorphisms: cancer implications. ...
  • Bartlett JMS. Ovarian Cancer Methods and Protocols. New Jersey: Springer; ...
  • Storey A, Thomas M, Kalita A, Harwood C, Gardiol D, ...
  • Khani H, Hosseinpourefeizi M, Pouladi N, Chaparzadeh N, Montazeri V, ...
  • Bhoo-Pathy N, Yip CH, Hartman M, Uiterwaal CS, Devi BC, ...
  • Leong SP, Shen ZZ, Liu TJ, Agarwal G, Tajima T, ...
  • Agarwal G, Pradeep PV, Aggarwal V, Yip CH, Cheung PS. ...
  • Coleman MP, Quaresma M, Berrino F, Lutz JM, De Angelis ...
  • Hjortsberg L, Rubio-Nevado JM, Hamroun D, Claustres M, Béroud C, ...
  • Feki A, Irminger-Finger I. Mutational spectrum of p۵۳ mutations in ...
  • Silwal-Pandit L, Vollan HK, Chin SF, Rueda OM, McKinney S, ...
  • Arcand SL, Akbari MR, Mes-Masson AM, Provencher D, Foulkes WD, ...
  • Olivier M, Petitjean A, Marcel V, Petre A, Mounawar M, ...
  • Lane D. p۵۳: out of Africa. Genes Dev ۲۰۱۶; ۳۰(۸):۸۷۶-۷ ...
  • Kung CP, Leu JI, Basu S, Khaku S, Anokye-Danso F, ...
  • Noma C, Miyoshi Y, Taguchi T, Tamaki Y, Noguchi S. ...
  • Hu Y, McDermott MP, Ahrendt SA. The p۵۳ codon ۷۲ ...
  • DeVita VT, Chu E. A history of cancer chemotherapy. Cancer ...
  • Cortes-Funes H, Coronado C. Role of anthracyclines in the era ...
  • Cheok CF, Lane DP. New developments in small molecules targeting ...
  • Burmakin M, Shi Y, Hedstrom E, Kogner P, Selivanova G. ...
  • Farnebo M, Bykov VJ, Wiman KG. The p۵۳ tumor suppressor: ...
  • Boeckler FM, Joerger AC, Jaggi G, Rutherford TJ, Veprintsev DB, ...
  • Joerger AC, Ang HC, Fersht AR. Structural basis for understanding ...
  • Essmann F, Schulze-Osthoff K. Translational approaches targeting the p۵۳ pathway ...
  • Diamandis M, White NM, Yousef GM. Personalized medicine: marking a ...
  • Collins F. Has the revolution arrived? Nature ۲۰۱۰; ۴۶۴(۷۲۸۹):۶۷۴-۵ ...
  • Cheok CF, Lane DP. New developments in small molecules targeting ...
  • Burmakin M, Shi Y, Hedstrom E, Kogner P, Selivanova G. ...
  • Farnebo M, Bykov VJ, Wiman KG. The p۵۳ tumor suppressor: ...
  • Joerger AC, Ang HC, Fersht AR. Structural basis for understanding ...
  • Essmann F, Schulze-Osthoff K. Translational approaches targeting the p۵۳ pathway ...
  • Diamandis M, White NM, Yousef GM. Personalized medicine: marking a ...
  • Collins F. Has the revolution arrived? Nature ۲۰۱۰; ۴۶۴(۷۲۸۹):۶۷۴-۵ ...
  • نمایش کامل مراجع